Angeles Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$370K Sell
999
-35
-3% -$12.4K 0.02% 321
2026
Q2
$371K Buy
1,034
+5
+0.5% +$1.53K 0.02% 339
2026
Q1
$258K Buy
1,029
+89
+9% +$22.1K 0.01% 352
2025
Q4
$259K Buy
940
+9
+1% +$2.46K 0.01% 317
2025
Q3
$244K Buy
931
+16
+2% +$3.89K 0.02% 293
2025
Q2
$200K Buy
+915
New +$196K 0.01% 339

Other funds holding WST

Angeles Wealth Management's WST Position: Q3 2026 in Review

Angeles Wealth Management reduced its West Pharmaceutical (WST) stake by 3.4% in Q3 2026, selling an estimated $12.4K and leaving 999 shares worth $370K. The position accounts for 0.02% of the portfolio, ranked #321.

Angeles Wealth Management first reported a position in WST in Q2 2025 and has held it in 6 quarters since. The position peaked at $371K in Q2 2026. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Angeles Wealth Management held 999 shares of West Pharmaceutical worth $370K as of Q3 2026.
  • Angeles Wealth Management sold 35 West Pharmaceutical shares in Q3 2026, an estimated $12.4K.
  • West Pharmaceutical made up 0.02% of Angeles Wealth Management's portfolio in Q3 2026, its #321 holding.
  • Angeles Wealth Management first reported a position in West Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
  • Angeles Wealth Management's West Pharmaceutical position peaked at $371K in Q2 2026.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Angeles Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.